The rise of GLP-1 therapy has been rapid, with usage rates among U.S. adults climbing from 3% to 11% in just two years. Despite this prevalence, many patients begin treatment without a long-term strategy for metabolic health. Dr. Salas-Whalen, an obesity medicine specialist with over 16 years of experience, aims to change this by providing a framework that moves beyond simple weight loss metrics.
Dr. Rocio Salas-Whalen Debuts MasterClass on GLP-1 Weight Loss Science
With 11% of American adults now using GLP-1 medications, a gap has emerged between public demand and clinical guidance. Endocrinologist Dr. Rocio Salas-Whalen is stepping in to bridge that divide, launching a new MasterClass designed to teach patients how to navigate these prescriptions safely and effectively.
Her course addresses the practical and biological realities of the medication, including strategies to manage common side effects like nausea and fatigue. Crucially, the curriculum focuses on muscle preservation, offering guidance on protein intake and strength training to ensure patients retain lean mass during treatment. Salas-Whalen emphasizes that GLP-1s are not transient diet trends but clinical tools for treating chronic conditions. By equipping patients with the knowledge to discuss dose escalation and biological factors with their own doctors, the class seeks to transform passive users into informed, empowered participants in their own medical care.
Comments (0)
No comments yet. Be the first!